The Learning Centre

Research

abs+ clinical trial to determine weight loss effects

By Genuine Health

Research by: Dr Kathee Andrews and Dr Venket Rao, University of Toronto.

MAIN OUTCOME: In a randomized, double-blind, placebo-controlled study, 34 adults over 30 years of age (BMI of 25 or more, waist circumference of 80cm or more for females and 94cm or more for males), were assigned randomly to either a control group who received six placebo capsules containing no active ingredients, or a treatment group who received six abs+ softgels – each containing 567mg CLA and 45mg of EGCG for a total daily intake of 3,400mg CLA and 270mg EGCG. A significant reduction in the body weight of subjects ingesting abs+ compared to placebo was observed: close to 60% of the subjects in the placebo group either gained weight or had no change during the course of the 12 weeks, whereas in the abs+ group 70% of the subjects either lost weight or had no change in their body weight.

Research published in the Journal of Herbs, Spices and Medicinal Plants 2006;12(3): 67-76.

Share: